Hikma Pharmaceutical | HIK - Créances Commerciales

Prix De L'Action
1,417.50
Variation Quotidienne
7.00 0.50%
Mensuellement
6.86%
Annuel
-29.27%
Q2 Prévisions
1,384.20




Créances Commerciales Changement Date
Almirall EUR 175.93M 17.87M 2025-12
argenx SE USD 1.66B 458.83M 2025-12
AstraZeneca USD 17.88B 1.17B 2026-03
Autolus Therapeutics Ltd USD 75.79M 15.57M 2025-12
Bayer EUR 14.19B 720M 2025-12
Fresenius EUR 3.78B 299M 2025-12
Galapagos EUR 199.75M 122.08M 2025-12
Genmab DKK 1.17B 119M 2025-12
GlaxoSmithKline GBP 7.94B 178M 2026-03
GRIFOLS EUR 958M 106M 2026-03
Hikma Pharmaceutical USD 1.08B 27M 2025-12
Lonza CHF 1.78B 55M 2025-12
Merck EUR 4.44B 293M 2025-12
Orion EUR 699.6M 270.4M 2026-03
Recordati EUR 699.76M 472K 2025-09
Roche Holding CHF 11.9B 460M 2025-12
Sanofi EUR 482M 85M 2026-03
UCB EUR 1.97B 54M 2025-12